HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Disposition of lypophilized (methylmethacrylate-14C, 2-hydroxyethylmethacrylate, butylacrylate) nanoparticles in rats and their effect on zoxazolamine paralysis time.

Abstract
The fate of lyophilized (methylmethacrylate-14C, 2-hydroxyethylmethacrylate, butylacrylate) nanoparticles was studied in male Wistar rats after p.o. administration. It was found that at least 4% of the dose of 14C was absorbed from the gastrointestinal tract after a single dose with these nanoparticles. Some radioactivity (less than 0.15% of dose) was found 7 d after administration in lung, spleen and liver. As expected excretion of the label was predominated via the feces. Ten d of p.o. treatment of rats with lyophilized nanoparticles (1 g/kg of body weight) was shown to prolong significantly zoxazolamine paralysis time. This result suggests that lyophilized nanoparticles decreased elimination of zoxazolamine.
AuthorsM Kukan, V Koprda, S Bezek, J Kálal, J Labský, T Trnovec
JournalDie Pharmazie (Pharmazie) Vol. 46 Issue 1 Pg. 37-9 (Jan 1991) ISSN: 0031-7144 [Print] Germany
PMID1857727 (Publication Type: Journal Article)
Chemical References
  • Acrylates
  • Delayed-Action Preparations
  • Methacrylates
  • Methylmethacrylates
  • Methylmethacrylate
  • hydroxyethyl methacrylate
  • n-butyl acrylate
  • Zoxazolamine
Topics
  • Acrylates (pharmacokinetics, pharmacology)
  • Administration, Oral
  • Animals
  • Delayed-Action Preparations
  • Feces (chemistry)
  • Freeze Drying
  • Intestinal Absorption
  • Male
  • Methacrylates (pharmacokinetics, pharmacology)
  • Methylmethacrylate
  • Methylmethacrylates (pharmacokinetics, pharmacology)
  • Microspheres
  • Paralysis (chemically induced, physiopathology)
  • Rats
  • Rats, Inbred Strains
  • Time Factors
  • Tissue Distribution
  • Zoxazolamine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: